VV-ECMO and COVID-19
VV-ECMO and COVID-19
Most patients with COVID-19 develop only mild symptoms. Approximately 5% of patients develop critical lung disease that requires a breathing tube and ventilatory support. When ventilatory support and other strategies are not enough to maintain adequate oxygenation values, VV-ECMO may be an option. VV-ECMO does not guarantee improvement in all COVID-19 patients with severe lung injury. Some patients who have severe lung scarring will require extended support. These patients may be considered for lung transplant if they meet eligibility criteria.